A practical guide to grant proposal rebuttal and resubmission strategy for NSF, NIH, and ERC — including how to decode panel summaries and what "not competitive" actually means.
Grant panel reviews operate under a fundamentally different logic than journal peer review, and the mistake most PIs make is treating them as interchangeable. A journal reviewer evaluates whether your work is correct and significant. A grant panel evaluates whether your proposed work is worth funding — which introduces dimensions (feasibility, team qualifications, budget justification, broader impacts) that journal reviewers never consider. The grant proposal rebuttal, in turn, must address a different species of concern: not "is this right?" but "will this work, and is it worth the money?"
This guide covers the specifics of responding to panel feedback from NSF, NIH, and ERC, along with the strategic decisions that determine whether a resubmission succeeds or wastes six months of your life.
How Grant Panel Reviews Differ from Journal Peer Review
The structural differences are worth stating explicitly, because they shape every aspect of the rebuttal strategy.
Panels evaluate proposals, not completed work. Journal reviewers can check your results, replicate your analysis, or verify your claims against the data. Grant panelists are evaluating a plan — and plans, by nature, involve uncertainty. The panel's job is to assess whether your plan is plausible, well-designed, and likely to produce meaningful results. Your rebuttal, therefore, must address concerns about feasibility and design as much as concerns about scientific merit.
Panel reviews are consensus documents. Unlike journal reviews (where Reviewer 1 and Reviewer 2 may hold diametrically opposed views), a grant panel summary represents the group's negotiated assessment. Individual reviewer scores may vary, but the summary reflects what the panel collectively decided matters. This means the summary carries more weight than any individual review, and contradicting it requires stronger evidence than contradicting a single journal reviewer.
Scores constrain the editor's (program officer's) discretion. At NSF and NIH, the program officer can fund proposals outside the top-ranked group, but doing so requires justification. A proposal that scored poorly cannot be rescued by a brilliant rebuttal alone — the scores need to improve on resubmission. The rebuttal is a means to that end, not an end in itself.
For the general principles of responding to reviewer feedback that apply across both journals and grants, see our guide to responding to peer review comments.
Decoding Panel Summaries: What the Language Actually Means
Grant panel summaries use a distinctive vocabulary that can be opaque to early-career PIs. The language is carefully chosen, and the specific phrases convey more information than they appear to at surface level.
"The proposal is not competitive" means the panel found fundamental weaknesses — in the research question, the methodology, or the team's qualifications — that cannot be fixed with minor revisions. This is not a signal to resubmit with cosmetic changes; it is a signal to rethink the project's core framing or scope.
"The proposal would benefit from a clearer articulation of…" is a precise diagnostic. Whatever follows that phrase is something the panel actively discussed and found wanting. Treat it as the highest-priority revision target.
"While the topic is timely, the proposed approach raises concerns about…" means the panel agrees the question is important but does not believe your plan for answering it is adequate. This is good news (the topic has support) wrapped in a specific critique (the design needs work).
"The investigator is well-qualified, but…" signals that the panel's concerns are not about you personally but about the proposal's design, scope, or feasibility. Do not take it as reassurance; take it as a redirect toward the specific weaknesses they identified.
"The broader impacts are underdeveloped" is one of the most common NSF criticisms and one of the easiest to fix. It usually means the broader impacts section was generic, vague, or clearly an afterthought.
NSF-Specific Guidance: How to Read and Respond to Panel Summaries
NSF proposals are evaluated on two merit review criteria: Intellectual Merit and Broader Impacts. Panel summaries address both, and your resubmission must show improvement on whichever criterion was weaker.
Reading the summary: NSF panel summaries typically begin with a brief characterization of the proposal, followed by strengths, weaknesses, and a summary assessment. The weaknesses section is your revision roadmap — every item listed there is something that at least one panelist raised and the group agreed (or did not disagree) was a legitimate concern.
The resubmission strategy for NSF: NSF does not have a formal "rebuttal letter" mechanism for most programs. Instead, you revise the proposal and resubmit it — sometimes to the same program, sometimes to a different one. The revised proposal should address the panel's concerns within the proposal itself, not in a separate response document. Some PIs include a brief "Changes from Previous Submission" section at the beginning; this is permitted by NSF guidelines and is useful for signaling to panelists (who may or may not be the same people) that you took prior feedback seriously.
Common NSF failure modes:
- Overpromising relative to timeline and budget. Panels are skilled at spotting proposals where the proposed work cannot realistically be completed with the resources requested.
- Weak preliminary data. For established programs, the expectation is that you have enough preliminary results to demonstrate feasibility — not enough to answer the research question (that is what the grant is for), but enough to show the approach works.
- Generic broader impacts. "We will train graduate students" is not a broader impacts plan; it is a description of what every funded project does by default. Specific, measurable, and ideally partnered broader impacts score substantially better.
NIH-Specific Guidance: Study Section Critiques
NIH uses a structured scoring system across five review criteria: Significance, Innovation, Approach, Investigator(s), and Environment. Each criterion receives a score (1–9, with 1 being the best), and the overall impact score reflects the panel's holistic assessment.
Reading the critique: NIH critiques are more structured than NSF summaries. Each reviewer provides individual scores and narrative comments for each criterion, followed by a discussion in the study section. The "Resume and Summary of Discussion" captures the key points from the group conversation — this is the most important section of the entire critique, because it reflects what the panel agreed on (not just what one reviewer thought).
Prioritizing your revision: Look at the criterion scores. If Approach scored a 5 but Significance scored a 2, the Approach section is where your revision effort belongs. A common mistake is distributing revision effort evenly across all criteria; the data (your scores) are telling you exactly where to focus.
The NIH resubmission mechanism: NIH allows one resubmission (the "A1"). The resubmission includes a one-page "Introduction to the Revised Application" that responds directly to the prior critique. This page is the closest thing in grant funding to a formal rebuttal letter, and it deserves the same strategic attention as a journal response document. Address every major concern. Be specific about what changed. Do not be defensive.
Common NIH failure modes:
- Underpowered study design. Study sections scrutinize sample size justifications, and a power analysis that does not align with the proposed aims will be flagged.
- Insufficient innovation. "We will apply existing method X to new population Y" is rarely innovative enough for R01 funding. The panel wants to see something that advances the field's methods or conceptual framework, not just its data.
- Approach lacks rigor. This is the most common weakness across NIH proposals. Rigor means pre-specified analyses, consideration of biological variables (sex, age), appropriate controls, and a clear plan for handling the full range of possible results — including null findings.
ERC-Specific Guidance: Panel Interview Preparation
The ERC process adds a dimension that neither NSF nor NIH uses: the panel interview (for proposals that pass the written review stage). The interview is typically 20–25 minutes, and it functions as a live rebuttal — panelists ask about the weaknesses identified in the written reviews, and your responses determine the final ranking.
Preparing for the interview: Request the written evaluations as early as possible and identify the two or three concerns that are most likely to come up. Prepare concise, evidence-based responses for each. The interview is not a presentation; it is a defense.
Common ERC interview mistakes:
- Overlong opening statement. Some panels give you 5–10 minutes for an opening. Use it to address weaknesses, not to re-present the proposal that the panelists have already read.
- Defensive responses to questions. The panelists are testing whether you can engage critically with your own proposal. Responding with "I believe my approach is correct" without evidence is the fastest way to lose points.
- Inability to articulate the contribution in one sentence. If you cannot state, clearly and without jargon, what your project will achieve that has not been achieved before, the panel will question whether the contribution is as significant as you claim.
The Resubmission Decision: Revise or Submit Elsewhere?
Not every unfunded proposal should be resubmitted to the same program. The decision depends on the nature of the feedback:
Resubmit to the same program when: the panel's concerns are specific and addressable (e.g., "needs more preliminary data," "approach section lacks detail," "broader impacts are generic"), and the panel's language suggests the project has merit that a stronger proposal could convey.
Submit elsewhere when: the panel's concerns are fundamental (e.g., "the research question is not significant," "this work has already been done"), the program fit was marginal to begin with, or you have reason to believe the panel composition was unfavorable and unlikely to change.
Rethink the project when: multiple panels or programs have returned similar criticisms, suggesting the issue is not presentation but substance.
The One Thing Most PIs Get Wrong About Resubmission
The most common error in grant resubmission is treating the panel critique as a checklist rather than a diagnosis. PIs read each comment, make the corresponding change, and resubmit — then are surprised when the revised proposal scores worse or receives new criticisms.
The reason this happens is that panel comments are symptoms, not causes. When a panel writes "the approach lacks rigor," checking a few boxes (adding a power analysis, mentioning blinding) addresses the surface critique but not the underlying problem, which may be that the entire research design does not convincingly demonstrate how the specific aims will be achieved. Addressing the symptom without treating the cause is a recipe for a second unfunded proposal.
The productive approach is to read the panel summary as a diagnostic narrative, not a to-do list. Ask: what is the overall story the panel is telling about why this proposal fell short? Then revise accordingly — sometimes that means restructuring the aims, sometimes it means adding substantial preliminary data, and sometimes it means fundamentally rethinking the approach. For the parallel process in journal revision, see our major revision response guide.
Responding to NSF, NIH, or ERC panel feedback? ReviewPanel.ai analyzes your proposal alongside panel critiques and generates a structured response plan with specific revision suggestions. $49/grant, no subscription.